U.S. market Closed. Opens in 4 hours 23 minutes

LLY | Eli Lilly and Company Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for LLY we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is stunning wealthy, Growth is very good and Health is weak.

Valuation (14%)

Company Industry
P/E Ratio (TTM) 84.31 76.61
PEG Ratio (TTM) 5.94 2.79
P/S Ratio (TTM) 18.19 7.31
P/B Ratio (TTM) 49.55 21.34
P/FCF Ratio (TTM) -341.23 -69.81
Price to 5YR AVG Earnings Ratio 127.61 49.13
Price to 5YR AVG FCF Ratio 251.35 76.25

Profitability (90%)

Company Industry
ROA (TTM) 11.07% 6.68%
ROE (TTM) 65.15% 34.95%
Net Profit Margin (TTM) 20.48% 13.64%
ROIC 5YR AVG 30.38% 20.65%

Growth (78%)

4QTR AVG 3YR AVG 5YR AVG
EPS 923.36% 28.57% 16.42%
Revenue 5.58% 9.73% 9.91%
Net Income 970.56% 22.39% 12.59%
Cash Flow 134.63% 11.21% -1.79%

Health (46%)

Company Industry
Current Ratio (TTM) 1.27 1.14
Quick Ratio (TTM) 0.97 0.89
D/E Ratio (TTM) 2.19 2.80
Interest Coverage (TTM) 23.91 13.95
Piotroski F-Score 4 6
Altman Z-Score 8.65 4.18
LTL to 5YR AVG FCF 6.19 4.08
Shares Outstanding Growth 5YR AVG -2.48% 0.69%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙